Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 23 Oct 2001, 0:00 Discovery Update With Regard To The Release Of
Discovery Holdings Ltd
SHARE CODE  :   DSY
ISIN CODE   :   ZAE000022331
Following the threat of court action by Discovery Health Medical Scheme
(`Discovery') against the Council for Medical Schemes (`Council'), Discovery
is pleased with the announcement by the Registrar of Medical Schemes
(`Registrar') that the process to release the KPMG report will be initiated
this week.
This will give Discovery and the Council the opportunity to reassure
Discovery's members and other stakeholders that Discovery conducts its
business in an appropriate manner.
As stated in previous communications and in the interests of openness and
transparency, the KMPG report covers the following areas:
Reinsurance:  Allegations have been made in the past around Discovery's use
of reinsurance.  In many instances these allegations have gone as far as to
allege reinsurance was used to `strip profits' from the medical schemes and
in some instances to allege fraud.  It was under this belief that a specific
mandate by the Council to KPMG was issued in order to thoroughly investigate
the use of reinsurance by Discovery and in this regard Discovery is
extremely comfortable with KPMG's findings and believing that KPMG's report
it clearly indicates Discovery's use of reinsurance was appropriate and
should continue.
The Registrar has stated that he disagrees with Discovery's interpretation
of the KPMG findings on reinsurance.  Discovery is therefore insistent that
the full report be released as soon as possible to clear the Discovery name.
Ancillary issues: The report raised a number of ancillary issues beyond the
scope of reinsurance.  Unfortunately the Council denied Discovery the
opportunity to review the issues raised by KPMG prior to the finalisation of
the report.  Consequently the final report excluded Discovery's specific
responses that would have rendered the report complete.  Discovery has
addressed all of these issues and while again comfortable would like KPMG to
confirm no unresolved issues exist.  In this regard the Registrar and the
Council have expressly forbidden KPMG from completing this exercise.
Accounting debate around RMB Structured Insurance (`RMBSI'): Discovery
entered into a structured insurance agreement with RMBSI to provide the
medical scheme with R200 million of capital together with stop loss coverage
for a five year period.  It is a matter of historic record that the
accounting treatment adopted by Discovery in respect of the RMBSI
transaction in it's audited financial statements to the year ending 31
December 2000 has been rejected by the Council.  Discovery has consequently
initiated a formal appeal process against this decision, which has been
delayed as a result of the Council not having constituted an appeal board.
When KPMG finalised their report in March the Discovery audited financials
were not yet complete and thus KPMG were not in a position to provide their
own final opinion on the accounting debate.  This matter is now beyond the
report and will be resolved during the appeal.
Discovery believes it is critical to the interests of its 1 million members
as well as other stakeholders that Discovery's good name and reputation be
maintained. Discovery is therefore in the process of showing that ,
notwithstanding any of the ancillary findings in the KPMG report (which have
been fully addressed ), that each and every decision and action taken by
Discovery and in particular its decision to make use of reinsurance  has
been and will continue to be in the best interest of its members.
Ends.
Contact: Shaun Matisonn, Principal Officer, Discovery Health Medical Scheme
Tel       : 011 529 2865
Fax       : 011 5295503
Email     : shaunm@discoveryhealth.co.za
Cell      : 082 606 2865
Contact   : John Bowen, Partner Financial Services, KPMG
Tel       : 011 647 7285
Fax       : 011 484 0510
Email     : john.bowen@kpmg.co.za
Contact: Rosemary Renton, Director, Corporate Communications Consultants
Tel       : 011 783-8926
Fax       : 011 783-7608
Email     : rosemaryr@corpcom.co.za
Cell      : 082 491 0364

Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: